Concepedia

Peter Sonnentag

PS

Statistics

Publications

7

Citations

290

H-Index

7

Active since

2009

Affiliations

Covance (United States)(Current)

Applied Genetic Technologies (United States)

University of Florida

LabCorp (United States)

University of Pennsylvania

Peter Sonnentag is an author at Covance (United States) specializing in medicine, ophthalmology, and ocular gene delivery.

Publications per year

2009–2018

7

Publications

7

Cone-Specific Promoters for Gene Therapy of Achromatopsia and Other Retinal Diseases

Guojie Ye, Ewa Budzynski, Peter Sonnentag et al. · Human Gene Therapy · 2015 · 84 citations

, , +13

Safety and Biodistribution Evaluation in Cynomolgus Macaques of rAAV2tYF-PR1.7-hCNGB3, a Recombinant AAV Vector for Treatment of Achromatopsia

Guo-jie Ye, Ewa Budzynski, Peter Sonnentag et al. · Human Gene Therapy Clinical Development · 2016 · 61 citations

, , +14

Safety and Biodistribution Evaluation in Cynomolgus Macaques of rAAV2tYF-CB-hRS1, a Recombinant Adeno-Associated Virus Vector Expressing Retinoschisin

Guojie Ye, Ewa Budzynski, Peter Sonnentag et al. · Human Gene Therapy Clinical Development · 2015 · 52 citations

, , +13

Safety and Biodistribution Evaluation of rAAV2tYF-CB-hRS1, a Recombinant Adeno-Associated Virus Vector Expressing Retinoschisin, in RS1-Deficient Mice

Guojie Ye, Thomas J. Conlon, Kirsten Erger et al. · Human Gene Therapy Clinical Development · 2015 · 29 citations

, , +15

Safety and Biodistribution Evaluation in CNGB3-Deficient Mice of rAAV2tYF-PR1.7-hCNGB3, a Recombinant AAV Vector for Treatment of Achromatopsia

Guo-jie Ye, Ewa Budzynski, Peter Sonnentag et al. · Human Gene Therapy Clinical Development · 2016 · 24 citations

, , +13

1–5 of 7